122 related articles for article (PubMed ID: 37293016)
21. Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia.
Yoshida M; Kataoka N; Miyauchi K; Ohe K; Iida K; Yoshida S; Nojima T; Okuno Y; Onogi H; Usui T; Takeuchi A; Hosoya T; Suzuki T; Hagiwara M
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2764-9. PubMed ID: 25675486
[TBL] [Abstract][Full Text] [Related]
22. Animal and cellular models of familial dysautonomia.
Lefcort F; Mergy M; Ohlen SB; Ueki Y; George L
Clin Auton Res; 2017 Aug; 27(4):235-243. PubMed ID: 28667575
[TBL] [Abstract][Full Text] [Related]
23. A neuron autonomous role for the familial dysautonomia gene ELP1 in sympathetic and sensory target tissue innervation.
Jackson MZ; Gruner KA; Qin C; Tourtellotte WG
Development; 2014 Jun; 141(12):2452-61. PubMed ID: 24917501
[TBL] [Abstract][Full Text] [Related]
24. Bone biomechanical properties and tissue-scale bone quality in a genetic mouse model of familial dysautonomia.
Vahidi G; Flook H; Sherk V; Mergy M; Lefcort F; Heveran CM
Osteoporos Int; 2021 Nov; 32(11):2335-2346. PubMed ID: 34036438
[TBL] [Abstract][Full Text] [Related]
25. Retrograde nerve growth factor signaling abnormalities in familial dysautonomia.
Li L; Gruner K; Tourtellotte WG
J Clin Invest; 2020 May; 130(5):2478-2487. PubMed ID: 32281946
[TBL] [Abstract][Full Text] [Related]
26. The familial dysautonomia disease gene
Chaverra M; George L; Mergy M; Waller H; Kujawa K; Murnion C; Sharples E; Thorne J; Podgajny N; Grindeland A; Ueki Y; Eiger S; Cusick C; Babcock AM; Carlson GA; Lefcort F
Dis Model Mech; 2017 May; 10(5):605-618. PubMed ID: 28167615
[TBL] [Abstract][Full Text] [Related]
27. IKBKAP mRNA in peripheral blood leukocytes: a molecular marker of gene expression and splicing in familial dysautonomia.
Gold-von Simson G; Leyne M; Mull J; Rolnitzky LM; Goldberg JD; Berlin D; Axelrod FB; Slaugenhaupt SA
Pediatr Res; 2008 Feb; 63(2):186-90. PubMed ID: 18091349
[TBL] [Abstract][Full Text] [Related]
28. Elongator promotes neuritogenesis
Shilian M; Even A; Gast H; Nguyen L; Weil M
Front Cell Dev Biol; 2022; 10():1015125. PubMed ID: 36393857
[TBL] [Abstract][Full Text] [Related]
29. Familial dysautonomia.
González-Duarte A; Cotrina-Vidal M; Kaufmann H; Norcliffe-Kaufmann L
Clin Auton Res; 2023 Jun; 33(3):269-280. PubMed ID: 37204536
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia.
Cheney AM; Costello SM; Pinkham NV; Waldum A; Broadaway SC; Cotrina-Vidal M; Mergy M; Tripet B; Kominsky DJ; Grifka-Walk HM; Kaufmann H; Norcliffe-Kaufmann L; Peach JT; Bothner B; Lefcort F; Copié V; Walk ST
Nat Commun; 2023 Jan; 14(1):218. PubMed ID: 36639365
[TBL] [Abstract][Full Text] [Related]
31. Elp1 is required for development of visceral sensory peripheral and central circuitry.
Tolman Z; Chaverra M; George L; Lefcort F
Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35481599
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice.
Sinha R; Kim YJ; Nomakuchi T; Sahashi K; Hua Y; Rigo F; Bennett CF; Krainer AR
Nucleic Acids Res; 2018 Jun; 46(10):4833-4844. PubMed ID: 29672717
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia.
Hervé M; Ibrahim EC
Dis Model Mech; 2016 Aug; 9(8):899-909. PubMed ID: 27483351
[TBL] [Abstract][Full Text] [Related]
34. A Comprehensive NMR Analysis of Serum and Fecal Metabolites in Familial Dysautonomia Patients Reveals Significant Metabolic Perturbations.
Costello SM; Cheney AM; Waldum A; Tripet B; Cotrina-Vidal M; Kaufmann H; Norcliffe-Kaufmann L; Lefcort F; Copié V
Metabolites; 2023 Mar; 13(3):. PubMed ID: 36984872
[TBL] [Abstract][Full Text] [Related]
35. Induced pluripotent stem cell (iPSC) lines from two individuals carrying a homozygous (BGUi007-A) and a heterozygous (BGUi006-A) mutation in ELP1 for in vitro modeling of familial dysautonomia.
Dor L; Rabinski T; Zlotnik D; Shilian M; Weil M; Vatine GD
Stem Cell Res; 2021 Aug; 55():102495. PubMed ID: 34419746
[TBL] [Abstract][Full Text] [Related]
36. RBM24 promotes U1 snRNP recognition of the mutated 5' splice site in the
Ohe K; Yoshida M; Nakano-Kobayashi A; Hosokawa M; Sako Y; Sakuma M; Okuno Y; Usui T; Ninomiya K; Nojima T; Kataoka N; Hagiwara M
RNA; 2017 Sep; 23(9):1393-1403. PubMed ID: 28592461
[TBL] [Abstract][Full Text] [Related]
37. Proteasome inhibitors to alleviate aberrant IKBKAP mRNA splicing and low IKAP/hELP1 synthesis in familial dysautonomia.
Hervé M; Ibrahim EC
Neurobiol Dis; 2017 Jul; 103():113-122. PubMed ID: 28404519
[TBL] [Abstract][Full Text] [Related]
38. Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia.
Close P; Hawkes N; Cornez I; Creppe C; Lambert CA; Rogister B; Siebenlist U; Merville MP; Slaugenhaupt SA; Bours V; Svejstrup JQ; Chariot A
Mol Cell; 2006 May; 22(4):521-31. PubMed ID: 16713582
[TBL] [Abstract][Full Text] [Related]
39. Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing.
Gold-von Simson G; Goldberg JD; Rolnitzky LM; Mull J; Leyne M; Voustianiouk A; Slaugenhaupt SA; Axelrod FB
Pediatr Res; 2009 Mar; 65(3):341-6. PubMed ID: 19033881
[TBL] [Abstract][Full Text] [Related]
40. Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia.
Axelrod FB; Liebes L; Gold-Von Simson G; Mendoza S; Mull J; Leyne M; Norcliffe-Kaufmann L; Kaufmann H; Slaugenhaupt SA
Pediatr Res; 2011 Nov; 70(5):480-3. PubMed ID: 21775922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
